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Essay
How to Make Evolution-Proof 
Insecticides for Malaria Control
Andrew F. Read*, Penelope A. Lynch, Matthew B. Thomas
Indoor residual spraying (IRS) with insecticides continues to be a mainstay of malaria control, having 
been responsible for often spectacular 
reductions in disease incidence during 
the 20th century, including elimination 
of malaria from many countries [1–4]. 
More recently, insecticide-treated bed 
nets (ITNs) have become a leading 
tool for malaria control [4,5]. Major 
international efforts are currently 
underway to comprehensively control 
and even globally eradicate malaria, 
and these involve enormous up-
scaling of IRS and ITN use [6–10]. As
in the last century, one of the major 
challenges to these new efforts is the 
evolution of insecticide resistance 
in Anopheles populations [1,2,11–
18]. IRS spraying for malaria was 
responsible for resistance evolution 
in countries as diverse as Greece, 
Java, Haiti, and Sudan [17,19–21]. 
Insecticide-resistant mosquitoes were 
one of the main hurdles faced by 
the ultimately unsuccessful Global 
Malaria Eradication plan in the middle 
of last century [1,2,11,13,14,17,22]. 
Contemporary experience is that 
nothing has changed. For instance, a 
surge in malaria cases from 600/month 
to 2,000/month in KwaZulu-Natal, 
South Africa, at the end of last century 
was associated with pyrethroid-resistant 
An. funestus [23,24]. In a recent 
24-village trial in Mexico, the frequency 
of pyrethoid-resistant Anopheles went 
from effectively zero to 20% after three 
years of IRS (Box 1) [25]. There are 
also serious concerns [16–18,26–31] 
and increasing evidence [32–34] that 
insecticides on bed nets will similarly 
drive resistance evolution.
Once a “resistance crisis” [26] 
occurs, where disease control fails 
because mosquito evolution has 
rendered an insecticide ineffective, 
options are few, not least because of 
the very limited insecticide arsenal 
available. Insecticides recommended 
for malaria control by the World 
Health Organization (WHO) represent 
just four classes of compound for IRS 
and just one class of compounds for 
ITNs [13,15]. Consequently, there 
is an increasing focus on resistance 
management strategies, whereby 
efforts are made to use existing 
insecticides in ways which can 
maximize the time period for which 
they provide useful disease control 
(what we hereafter refer to as the 
“useful lifespan” of a compound). 
Resistance management strategies 
include the use of diverse insecticides 
in space and time (rotations and 
mosaics), insecticide mixtures, and 
restricting use to specific risk periods 
and locations [13,25,26,31,35–38]. 
Resistance management requires 
on-going surveillance [14,17] and 
a level of application management 
that is frequently problematic in 
regions where the malaria challenge 
is most severe. Moreover, techniques 
such as rotations and mixtures can 
be undermined by issues of cross 
resistance [13]. Indeed, given current 
restrictions on approved chemicals, 
there are virtually no options for 
resistance management for ITNs. 
Consequently, there is now a 
concerted effort to identify new 
insecticidal compounds for use in 
malaria control [36,39]. On the face of 
it, this is desirable, but novel chemistry 
does not, in itself, provide a sustainable 
answer. All existing insecticides were 
“new” at some point, and there is 
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Insecticides are one of the cheapest, 
most effective, and best proven methods 
of controlling malaria, but mosquitoes 
can rapidly evolve resistance. Such 
evolution, first seen in the 1950s in 
areas of widespread DDT use, is a 
major challenge because attempts to 
comprehensively control and even 
eliminate malaria rely heavily on indoor 
house spraying and insecticide-treated 
bed nets. Current strategies for dealing 
with resistance evolution are expensive 
and open ended, and their sustainability 
has yet to be demonstrated. Here we 
show that if insecticides targeted old 
mosquitoes, and ideally old malaria-
infected mosquitoes, they could provide 
effective malaria control while only 
weakly selecting for resistance. This 
alone would greatly enhance the useful 
life span of an insecticide. However, 
such weak selection for resistance can 
easily be overwhelmed if resistance is 
associated with fitness costs.  In that case, 
late-life–acting insecticides would never 
be undermined by mosquito evolution. 
We discuss a number of practical ways 
to achieve this, including different 
use of existing chemical insecticides, 
biopesticides, and novel chemistry. Done 
right, a one-off investment in a single 
insecticide would solve the problem of 
mosquito resistance forever.
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the very real danger that, as with the 
antimalarial drug treadmill [40], the 
search for products can become open 
ended as the efficacy of successful 
new compounds is, in turn, eroded 
by the evolution of resistance. Here 
we show that the natural history of 
the Anopheles–Plasmodium interaction 
makes possible an alternative strategy 
to deal with insecticide resistance: 
the development of insecticides with 
properties that retard and even entirely 
prevent the spread of resistance. An 
“evolution-proof” compound would 
provide sustainable control, render 
conventional resistance management 
strategies unnecessary, and completely 
avoid an insecticide treadmill.
The Proposition
All current insecticides approved for 
ITNs or IRS kill extremely rapidly after 
contact, and some are also irritants 
that cause the mosquito to move away 
from the net or house and search for 
blood meals elsewhere. Where coverage 
is high (a requirement for effective 
control), insecticides greatly reduce 
malaria transmission, but their high 
lethality or interference with blood 
feeding also imposes intense selection 
for resistance. It is our contention that 
effective transmission reduction can be 
achieved while minimizing selection 
for resistance. To simplify the following 
discussion, we initially consider only the 
lethal effects of insecticides; we return 
to the irritant (excito-repellency) 
effects at the end.
Our argument derives from the 
following observations. First, female 
mosquitoes convert a blood meal 
into eggs and oviposit in appropriate 
water bodies before seeking the next 
blood meal. This gonotrophic cycle 
takes 2–4 d [41,42]. Females contact 
insecticides on bed nets during feeding 
attempts, or on house walls while resting 
immediately after the feed. Second, 
extrinsic mortality rates for the key 
vector species, even in the absence of 
any public health measures, are very 
high—on the order of 10% per day or 
20–40% per gonotrophic cycle [41,42]. 
The consequence is that most females 
go through only a few gonotrophic 
cycles before they die. Third, after 
infecting mosquitoes, malaria parasites 
go through various developmental 
stages and very many replicative cycles 
before migrating to the salivary glands, 
from where they can be transmitted to 
humans. The duration of this process 
(the sporogonic or extrinsic incubation 
period) depends on host, parasite, and 
environmental factors, but it is in the 
order of 10–14 d or 2–6 gonotrophic 
cycles in areas of high malaria 
transmission [41,42]. These facts 
together lead to one of the great ironies 
of malaria: most mosquitoes do not live 
long enough to transmit the disease. 
These facts also mean that the 
majority of eggs a female will produce 
in her lifetime are laid in the window 
before malaria-infected mosquitoes can 
become dangerous to humans. Thus, 
in principle at least, public health 
advances can be achieved with minimal 
selection for resistance by an insecticide 
that kills after the majority of mosquito 
reproduction has occurred but before 
malaria parasites are infectious. Unlike 
in agriculture, the aim here is disease 
control, not necessarily insect control. 
Below we consider how insecticides 
could be designed so as to kill only 
older mosquitoes, but we first compare 
the transmission control potential 
and the evolutionary properties of 
our proposed late-life–acting (LLA) 
insecticides with compounds like 
dichloro-diphenyl-trichloroethane
(DDT), pyrethroids, and others 
currently in use (“conventional”’ 
insecticides). The first key question 
is whether LLA insecticides can offer 
significant reductions in malaria 
transmission.
Control
To assess the malaria control potential 
of LLA insecticides, we followed 
others [42–44] in developing a 
simple feeding cycle model (FCM) 
that deterministically tracks discrete 
cohorts of mosquitoes through their 
gonotrophic cycles, where mosquitoes 
have fixed probabilities of becoming 
infected with malaria parasites and, 
in our case, exposed to insecticides. 
The background mosquito mortality 
rates and durations of sporogony used 
to parameterize the baseline model 
are the average of four Plasmodium
falciparum–endemic sites, two in 
Nigeria, one in Tanzania, and one in 
Papua New Guinea [42]. These sites are 
intense foci of malaria transmission. 
An LLA insecticide could 
disproportionately kill older 
mosquitoes in two ways. First, it might 
work some time after first exposure 
(a time-dependent killer), as might 
be the case for an infectious agent. 
Second, the insecticide might be 
disproportionately effective against 
older mosquitoes, irrespective of time 
since contact (age-dependent killer), 
as might be the case if older insects 
are more physiologically vulnerable. In 
the following analysis, we consider this 
latter type of LLA insecticide, but our 
conclusions are unaltered in either case 
(Table S1). 
The evolution of insecticide 
resistance is a practical problem only 
where insecticide coverage is high, 
which we take here to be 80%, a 
minimum target for coverage with 
IRS or ITNs [10]. For computational 
simplicity, we also assume that LLA 
insecticides have no impact on 
either total mosquito densities or 
the proportion of humans that are 
infectious. With these assumptions (and 
others, see Materials and Methods), 
we calculate that LLA insecticides 
killing mosquitoes that have reached 
2 or more gonotrophic cycles will 
reduce the number of infectious bites 
by 99.2%. The corresponding figures 
for 3- and 4-cycle killers are 97.9% and 
94.2%, respectively. These figures are 
highly encouraging, especially as they 
are minimum estimates: reductions in 
the number of infectious human cases 
following intervention will further 
reduce the number of infectious 
mosquitoes, as would higher or more-
effective insecticide coverage and any 
effects on mosquito densities (more 
likely the earlier-acting the insecticide).
Evolution
While fast-acting conventional 
insecticides can produce even more 
effective initial control (in our analysis, 
a 99.8% reduction in the number 
of infectious bites), they impose 
enormous selection for resistance 
by killing young female adults. The 
consequence is that spectacular initial 
mosquito control can last as little as 
a few years, thus providing very poor 
medium- to long-term disease control, 
as history has shown [22]. To analyze 
the evolutionary sustainability of 
LLA insecticides, we used fecundities 
calculated in our feeding cycle model 
as input into a discrete-time analog of 
standard population genetics models 
to track the spread of single-allele 
resistance through the population. 
Frequency of resistance in a population 
was calculated by assuming that 
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resistance is dominant and ablates 
the mortality effects of the insecticide 
in question. We discuss the effect of 
relaxing the dominance assumption, 
and other assumptions, in Text S1.
With parameters as above, resistance 
spreads considerably more slowly for 
LLA insecticides than for conventional 
insecticides (Figure 1). This is because 
insecticides that kill on first contact will 
reduce mosquito lifetime reproductive 
success by about 85%. In contrast, 
insecticides that kill mosquitoes that 
have reached at least their fourth 
gonotrophic cycle eliminate just 22% of 
progeny (Figure 1). Thus, all else being 
equal, the fitness of a mutant resistant 
to conventional insecticides is 6.5 times 
that of the susceptible wild type; the 
corresponding advantage for a four-
cycle killer is just 1.28. 
The evolution of resistance to LLA 
insecticides could be slowed even 
further if they were disproportionately 
effective against malaria-infected 
mosquitoes. This is because insecticides 
that are less likely to kill uninfected 
mosquitoes further relax selection for 
resistance without any loss of control. 
For instance, if we leave the probability 
that a four-cycle LLA insecticide would 
kill infectious mosquitoes unaltered 
but halve its likelihood of killing 
uninfected mosquitoes, the time taken 
for resistance to reach 50% frequency 
would increase by about half as much 
again. A potentially useful side effect 
of disproportionate killing of malaria-
infected mosquitoes would be to 
increase the selection pressure favoring 
malaria-resistant mosquitoes [45,46].
Importantly, resistance to LLA 
insecticides will not spread at all if there 
are nontrivial fitness costs to insecticide 
resistance. Reduced fitness of resistant 
insects in the absence of insecticides 
is frequently reported [47–49]. For 
Anopheles, costs of resistance have 
been seen in the laboratory [50,51] 
and, in the field, unexpectedly low 
frequencies of resistant homozygotes 
(e.g., [52]), and declines in resistance 
after withdrawal of causal insecticide 
(e.g., [18,25]) (see Box 1) point 
to substantial fitness costs. Costs of 
resistance have little impact on the 
evolution of resistance to conventional 
insecticides where the benefits of 
resistance are so high. The situation 
is, however, very different for LLA 
insecticides, where the fitness benefits 
of resistance (Figure 1) are very much 
lower. For LLA insecticides, resistance 
costs can outweigh resistance benefits, 
preventing resistance spreading at all, 
even when resistance alleles are present. 
This argument follows from the 
evolutionary theory of aging [53–57]. 
The strength of selection declines 
with age. Beneficial genes that act late 
in life can fail to spread if they are 
associated with fitness costs earlier in 
life. This is because all individuals pay 
these costs, whereas only those few that 
survive to old age benefit. The theory 
of aging is well verified, not least in 
insects [58]. Senescence does occur in 
mosquito populations, and in Anopheles
is detectable around the age at which 
mosquitoes can first become infectious 
to humans [59–62]. Thus, natural 
selection has not been strong enough 
to favor beneficial alleles that would 
act around the same time as would a 
putative resistance allele against a late-
life insecticide. 
The inclusion of even modest 
costs of resistance substantially slows 
the rate at which resistance to LLA 
insecticides spreads in a population, 
thus considerably prolonging the 
effectiveness of malaria control (Figure 
2). Importantly, it is also possible to 
maintain the initial levels of control 
forever. For the particular parameter 
values used here, costs of resistance, 
which accrue as an additional 
daily mortality rate of 3.4%, would 
doi:10.1371/journal.pbio.1000058.g001
Figure 1. Evolutionary Consequences of Insecticides That Are Highly Lethal Immediately 
after First Contact (Conventional Insecticides, like DDT and Pyrethroids, Con) and 
Hypothetical LLA Insecticides That Kill Mosquitoes from Their Second through Sixth 
Gonotrophic Cycles (C2-C6) 
(A) Frequency of resistant mosquitoes through time. (B) Impact of insecticides on fitness of 
susceptible mosquitoes, and relative fitness of resistant mosquitoes in presence of insecticides, 
assuming no costs of resistance. LLA insecticides are a substantially less potent driver of the 
evolution of resistance than are conventional insecticides because of their susbstantially smaller 
impact on mosquito fitness. Note that when first deployed, four-cycle LLAs reduce the number 
of infectious bites by 94.2%. Two- and three-cycle killers remove more, but at cost of increased 
selection for resistance. We assume the control offered by five- and six-cycle killers, 76.6% and 
57.1% of infectious bites removed, is too low to make them practicable (although absolute levels 
of control required will depend on local epidemiological context and the availability of other 
disease management tools). For model details and parameter values, see Materials and Methods. 
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render a four-cycle LLA insecticide 
completely evolution proof: this is 
the point at which the fitness gains of 
resistance, which benefit only a few, 
are outweighed by the fitness costs of 
resistance, which are paid by all. Thus,
in principle at least, it is possible to 
create an insecticide that would provide 
effective malaria control yet never 
be undermined by the evolution of 
resistant mosquitoes.
The cost of resistance required 
to get evolution proofing is lowered 
for LLA insecticides which are 
disproportionately effective against 
malaria-infected mosquitoes (Figure 
3). For instance, a four-cycle LLA 
insecticide, which is half as likely to 
kill uninfected mosquitoes, requires 
a cost of resistance of just 2.3% to be 
completely evolution proof. Strikingly, 
if its effectiveness against uninfected 
mosquitoes was just 10% of what it was 
against infected mosquitoes, complete 
evolution proofing would occur at 
a resistance cost of just 0.9%, a cost 
which would be barely measurable. An 
LLA insecticide that kills only malaria-
infected mosquitoes is completely 
evolution proof for vanishingly small 
costs of resistance (0.43%).
We are aware of only one quantitative 
estimate of the relative fitness of 
resistant mosquitoes in the field. This 
comes from the non-malarial vector 
Culex pipiens, following 40 years of 
organophosphorous (OP) insecticide 
spraying in Southern France [48,63]. 
There, the fitness of individuals 
homozygous for a resistance mutation 
relative to sensitive homozygotes is 
0.63–0.72 (discussed further in Text 
S1). Using our model to calculate 
lifetime fecundity of mosquitoes 
experiencing various mortality 
costs of resistance in the absence of 
treatment, we find that the relative 
fitness associated with the highest cost 
of resistance required to get complete 
evolution proofing, 3.4% additional 
mortality, is 0.78; the corresponding 
figures for the 2.3% and 0.9% 
additional mortality described above 
are 0.84 and 0.93, respectively. Similar 
figures are obtained if we assume the 
costs of resistance accrue as reduced 
fecundity rather than reduced adult 
survival (unpublished data). Thus, the 
costs of resistance required to achieve 
complete evolution proofing are not 
out of line with those seen in nature.
Product Options
The foregoing analysis argues 
that new insecticides for malaria 
control should minimize impact 
on mosquito lifetime reproductive 
output while also minimizing the 
number of infectious mosquitoes. 
The achievement of this goal ideally 
requires insecticides that kill late in life, 
that are disproportionately effective 
against malaria-infected mosquitoes, 
and for which resistance carries fitness 
costs. This approach, which will 
retard the spread of resistance alleles 
(possibly forever) even when they 
are already present in a population, 
should complement or even replace 
strategies aimed solely at delaying the 
initial origin of resistance, since these 
latter strategies often have no effect 
when resistance eventually becomes 
established in a population.
We are unaware of any attempts to 
evaluate potential insecticides for these 
properties, but it is possible to imagine 
a range of approaches or modes of 
action that would achieve late-life 
killing. For example, cumulative 
exposure to ordinarily sublethal doses 
of an insecticide over multiple feeding 
cycles could result in the death of older 
mosquitoes. Alternatively, formulation 
techniques such as microencapsulation 
could provide a means for slow release 
of an insecticide over time. Similarly, 
age-dependent mortality could be 
achieved by exploiting the fact that 
in Anopheles, metabolic detoxification 
activity declines with age [29,64]. This 
decline may be a natural consequence 
of senescence and explain why 
Anopheles become more susceptible to 
DDT, malathion, and pyrethroids with 
increasing age [64–68]. It is also easy 
to imagine compounds that would act 
disproportionately on mosquitoes with 
advanced malaria infections. Malaria 
parasites impose large metabolic costs 
on mosquitoes [69–73], either directly 
via competition for resources, or 
indirectly by prompting costly immune 
responses. These costs are likely to 
increase as the malaria infection 
progresses, both as a consequence 
of the increasing parasite burdens as 
replication proceeds, and as blood 
and other meals become progressively 
less successful as the mouthparts 
become blocked with sporozoites [74]. 
Metabolically stressed insects should be 
more vulnerable to normally sublethal 
doses or compounds. 
An even more radical possibility 
is that there may be formulations 
or deployment strategies that would 
convert existing insecticides into 
doi:10.1371/journal.pbio.1000058.g002
Figure 2. Evolutionary Consequences and Control Effectiveness of Insecticide Where There 
Are No Costs of Resistance (+0%) or Where the Costs of Resistance Accrue as Additional Daily 
Mortality Rates as Shown 
(A) Frequency of resistant mosquitoes through time. (B) Control effectiveness through time, where 
0% effectiveness is the situation prior to the insecticide application, and 100% is complete absence 
of infectious bites. Plotted values are for a conventional insecticide (Con) or an LLA insecticide that 
kills mosquitoes on contact during or after their fourth gonotrophic cycle (a 4C LLA in Figure 1). 
Beyond the duration of our simulations, the LLA insecticide eventually fails even for a 2% cost of 
resistance (green line); for the parameter values used here, complete evolution-proofing occurs at 
3.4%. For model details and parameter values, see Materials and Methods. 
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evolution-proof LLA insecticides. As 
noted above, DDT, pyrethroids, and 
malathion are disproportionately 
efficacious against mosquitoes that 
are old enough to transmit malaria 
[64–68]. Doses lower than those 
currently recommended may therefore 
be insufficient to kill younger 
mosquitoes but fatal to older, near-
infectious mosquitoes. If so, existing 
insecticides could be evolution-proofed 
by changing concentrations delivered 
in the field, even where resistance is 
currently spreading in a population.
The evolutionary benefits of an LLA 
insecticide apply irrespective of the 
resistance mechanism involved, but the 
greatest benefits accrue for compounds 
against which resistance is the most 
costly. Resistance to conventional 
insecticides involves target site 
alterations, metabolic detoxification, 
and behavioral avoidance [2,12,13]. 
It seems highly likely that the fitness 
costs of resistance will depend on 
the mechanisms involved. In other 
insects, there is evidence that fitness 
costs depend on the insecticide, and 
for some but importantly not all, 
the costs can clearly be negligible or 
degrade through time as modifiers 
spread [63,75]. Explicit deployment of 
compounds against which resistance is 
costly would be a novel approach and 
would also assist traditional resistance 
management strategies.
There may also be ways of achieving 
evolution-proof insecticides by means 
other than chemicals. For example, 
fungal biopesticides are already 
known to generate the required 
phenotypes. These insecticides are 
based on oil-formulated spores of 
entomopathogenic fungi applied to 
surfaces on which adult mosquitoes 
will rest after blood feeding [46,76,77]. 
Although still at a research stage, they 
have proven to be very effective malaria 
transmission blockers in the laboratory 
[76] and can be delivered in African 
houses [77]. Fungal biopesticides 
work as time-dependent late-life 
insecticides, killing the insect 7–14 d 
post-contact [46,76–79]. They are also 
disproportionately effective against 
malaria-infected mosquitoes [76]. Other 
biocontrol agents such as Wolbachia [80] 
and densoviruses [81] have a similar 
potential to disproportionately target 
older mosquitoes [82], and hence are 
potentially immune to the evolution of 
host resistance. 
Moreover, nothing in our arguments 
actually requires compounds that 
kill mosquitoes. Critical is that older, 
infectious mosquitoes be prevented 
from biting humans. Killing them is 
one way of doing this, but analogous 
arguments would apply to products 
which, late in life, have other 
transmission-blocking effects, such 
as interference with host-seeking 
behavior, flight, or blood feeding 
propensity. Sublethal effects like 
these must have pronounced fitness 
consequences for mosquitoes but, as 
with lethality, these need not result in 
strong selection for resistance so long 
as they impact in later life. Fungal 
biopesticides reduce feeding propensity 
as infection progresses [76,83]. 
Irritancy is an important feature of the 
protection offered by some existing 
chemical insecticides like pyrethroids, 
because it drives mosquitoes out of 
houses and in search of other hosts 
[33]. For highly anthrophilic species, 
like An. gambiae, evolution-proofing 
an irritant would require that it be 
selectively excito-repellent to older 
mosquitoes. For vector species that 
are not particularly anthrophilic, an 
insecticide that achieved irritancy 
without lethality would impose 
negligible selection for resistance at 
any age if the fecundity and survival 
of mosquitoes feeding on nonhuman 
hosts was no lower. 
Complications and Possible 
Downsides
Exploiting the ideas advocated above 
requires that criteria used to evaluate 
insecticides for malaria control be 
broadened beyond those currently 
now in use. Current minimum target 
product profiles required by the WHO 
Pesticide Evaluation Scheme for Phase 
1 (laboratory) testing of insecticides 
for ITN and IRS use are 80% mortality 
up to 24 h post-exposure in young 
(2–5 d post-emergence) adult female 
Anopheles [84,85]. These thresholds, 
little changed since the 1960s [86], are 
used by the WHO to determine which 
insecticides to recommend to national 
authorities, and consequently by others 
to determine candidate compounds 
for inclusion in product development 
portfolios (for example, the Innovative 
Vector Control Consortium; 
http://www.ivcc.com/workwithus/
application_process/irs.htm; accessed 
4 March 2009). However, these “young-
kill” criteria will result in the use of 
insecticides that impose near maximal 
selection for resistance. Minimizing that 
selection while still providing malaria 
control requires the use of insecticides 
and application protocols that impose 
marked reductions in transmission 
potential while simultaneously 
minimizing reductions in mosquito 
fitness. Assessing that requires exposing 
doi:10.1371/journal.pbio.1000058.g003
Figure 3. Fitness of Resistant Mosquitoes Relative to Susceptibles for an LLA Insecticide 
for Various Costs of Resistance and Differential Efficacy against Malaria-Infected 
Mosquitoes
When relative fitness is greater than 1, resistance spreads, when relative fitness is less than 1, 
resistance can never spread, even when present in a population (complete evolution-proofing). 
Plotted values are for an LLA insecticide which kills mosquitoes on contact during or after their 
fourth gonotrophic cycle; these remove 94.2% of infectious mosquitoes when first deployed. 
Differential mortality is the proportionate reduction in mortality for uninfected mosquitoes 
compared to malaria-infected mosquitoes. Costs of resistance accrue as additional daily mortality 
rates. Relative fitness for conventional insecticides is 6.5 (Figure 1), which is little affected by costs 
resistance (see text). For model details and parameter values, see Materials and Methods. 
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cohorts of young and old mosquitoes to 
insecticides, and analyzing life-long life 
tables, propensity to blood feed and, 
critically, fecundity, all ideally done 
with malaria-infected mosquitoes going 
through regular gonotropic cycles. 
Such experiments are not technically 
demanding, but they are logistically 
challenging, so that it would be 
impractical to do such tests for 
thousands of candidate compounds. 
However, for a limited number of 
promising candidates, such tests are 
feasible [46,76–79]. Candidates could 
be chosen in a number of ways. First, 
highly lethal compounds already at 
an advanced stage of development 
(or even registered) could be tested 
at lower concentrations for LLA 
properties. Second, known compounds, 
possibly rejected in previous screens 
because of slow speed of kill, could 
be revisited. Third, other product 
evaluation criteria such as likely cost, 
environmental safety, and potential 
for cross resistance could be used 
to preselect candidates for LLA 
testing from among the thousands 
of compounds currently tested in 
standard protocols. With lower 
lethality as a requirement, many more 
compounds might become feasible 
public health tools. We note that when 
it costs >US$175 million to bring a 
new compound into use [10], even 
substantially higher initial development 
Box 1. A Contemporary Example of the Selection of Insecticide Resistance by Indoor Residual Spraying
Some of the best data on the impact 
of malaria control insecticides on 
resistance in Anopheles come from 
the Pacific Coast of Chiapas, Mexico 
[25,92,93]. In this region, agricultural 
use of insecticides around mosquito 
breeding sites together with indoor 
residual spraying of DDT for malaria 
control resulted in high levels of 
resistance to organochlorines, 
organophosphates, carbamates, and 
pyrethroids by the end of the 1970s. 
In the 1980s and ‘90s, DDT continued 
to be used for malaria control, and 
DDT resistance remained at high 
levels. However, the agricultural use of 
insecticides declined markedly, so that 
by the mid-1990s, resistance to all other 
classes of insecticides had regressed 
to the point where it was barely 
detectable in standard WHO bioassays 
[93]. Genetic and biochemical analyses 
confirmed that, nonetheless, several 
known resistance alleles remained in these 
populations.
In the latter half of the 1990s, a 24-village IRS trial was conducted, aimed at evaluating the effect of contrasting resistance 
management strategies on the evolution of resistance [25,92,93]. This trial was prompted by rising concerns that the practice of using 
insecticides until resistance became a limiting factor was rapidly eroding the number of insecticides available for malaria control. 
Villages were assigned to one of four treatments of repeated cycles of house-spraying: (i) two spray applications per year of DDT, or 
three applications per year of (ii) a pyrethroid, (iii) a spatial mosaic of an organophosphate and a pyrethroid, or (iv) an annual rotation 
of an organophosphate, a pyrethroid, and a carbamate. 
Over the three years of the trial, pyrethroid resistance increased markedly in the mosquito populations in all villages, irrespective of 
insecticide treatment (Figure 4). Thus, spray campaigns targeting mosquitoes in an age-independent manner can very rapidly drive 
resistance evolution when relevant alleles are present in a population. Presumably, the majority of mosquitoes in all villages would 
have been resistant had the trial continued a few more years. This trial was well resourced and monitored, so that the insecticide 
coverage achieved was likely to be as high is practically possible, and thus representative of an IRS campaign confering maximal 
possible malaria control.
Resistance measures based on forcefully exposing mosquitoes to insecticide, such the WHO bioassays used to generate the data 
in the figure, likely under estimate epidemiologically relevant resistance because they can not assay important forms of resistance 
such as behavioral avoidance. Moreover, even resistance to direct exposure can be due to many different mechanisms and there 
can be many genetic variants in any one biochemical pathway. Thus, the contribution of any particular allele to overall resistance 
varies substantially. In this trial, levels of cytochrome P450, a major determinant of resistance to pyrethroids, were maintained at high 
levels only in villages sprayed solely with pyrethroids. In villages sprayed with DDT or subject to the rotation scheme, cytochrome P450
levels declined below detectability [25]. This suggests that cytochrome P450-mediated resistance can be managed by switching to a 
different insecticide class, but also that such switches need not limit resistance at the whole-insect level (Figure 4). It is our contention 
that evolution-proofing is possible for all resistance mechanisms, even where they already exist in a population, by targeting older 
mosquitoes.
doi:10.1371/journal.pbio.1000058.g004
Figure 4. Evolution of Insecticide Resistance over Three Years of Indoor Residual Spraying in 
Coastal Southern Mexico. 
Pyrethroid resistance was assessed using WHO susceptibility bioassays before intervention (year 0) 
and over three years of different insecticide spraying regimes. Redrawn from [25]. 
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costs for one LLA product look good 
against the costs of having to develop 
a second and third conventional 
insecticide (potentially ad infinitum 
if malaria can not be eradicated or 
controlled some other way). They 
also look good against the indefinite 
implementation costs and logistic 
constraints of resistance management 
strategies such as rotations or mosaics, 
which are currently being investigated 
as a means to prolong the life of 
existing, fast-acting insecticides once 
resistance is present (Box 1). 
One side effect of the highly lethal 
insecticides currently in use for malaria 
control is that they also kill nontargets, 
such as nuisance mosquitoes and 
bedbugs. This side-effect is believed 
to help with householder compliance 
and uptake [3,37,87], at least before 
the nontargets also evolve resistance. 
LLA insecticides would not have these 
immediately beneficial side effects 
(although a product with differential 
impact against primary targets and 
secondary targets is a possibility). As 
such, LLA insecticides would essentially 
be community-level interventions, 
like transmission-blocking vaccines, 
with the associated issues of user 
take-up. Accordingly, it maybe that 
LLA insecticides will require delivery 
mechanisms that provide some degree 
of personal protection against nuisance 
insects, like bed nets, or imaginative, 
culturally-sensitive delivery systems 
and education programs that facilitate 
adoption irrespective of immediate 
personal relief from biting insects. 
The late-life killing insecticides we 
are proposing here work because of 
the time Plasmodium takes to develop 
in mosquitoes. Could these insecticides 
select more rapidly developing 
parasites [82,88]? They might, but the 
short lives of mosquitoes must already 
be imposing intense natural selection 
for shorter extrinsic incubation 
periods, a selection pressure that must 
be further exacerbated by conventional 
insecticides. The apparent lack of 
response to this selection implies that 
significant fitness gains result from 
prolonged development [46,89], gains 
which presumably accrue through 
increased infectiousness [74]. It 
might be that LLA insecticides would 
add sufficient additional selection to 
offset these, but if it did, the resulting 
evolution would presumably generate 
substantially less-fit malaria parasites. 
Further investigation of this possibility 
is certainly warranted; in the meantime 
we note that the hypothetical 
evolution of significantly less-infectious 
parasites must be of less public health 
significance than the observed failure 
of existing insecticides in the face of 
resistance evolution.
For equivalent levels of coverage (at 
least lower than 100%), conventional 
insecticides will always give better 
control initially, before any resistance 
evolution. This disparity widens as 
coverage drops (unpublished data). 
Indeed, if only poor coverage can be 
achieved, the control benefits of LLA 
insecticides may be negligible. However, 
in that case, the need for them is 
also negligible, because resistance 
evolution is much less of a problem at 
low coverage, where insecticides of any 
type will impose weaker selection for 
resistance. LLA insecticides come into 
their own when coverage is high, an 
explicit aim of ITN and IRS programs, 
particularly in intense transmission 
areas. At high coverages, sustained 
reductions in transmission of ~95% 
by an LLA insecticide will quickly out 
weigh the even higher reductions that 
are initially possible with conventional 
insecticides once resistance against 
the latter inevitably spreads. Even 
LLA insecticides which fall short of 
being completely evolution-proof will 
minimize the evolutionary pressures 
that otherwise rapidly erode the efficacy 
of conventional insecticides. Very much 
slower rates of increase of resistance 
give more time for surveillance to 
detect resistance problems (or less 
frequent surveillance to provide the 
same warning), and more time to 
react. Lower selection pressures can 
also translate into many decades of 
additional effective control, which from 
a practical control perspective may be 
essentially infinite. 
Concluding Remarks
Somewhat ironically, given that all 
the insecticides currently in use in 
the public health sector derive from 
products developed for the agricultural 
sector, the long-term sustainability 
of LLA insecticides could be further 
enhanced precisely because they are 
likely to have little utility in agriculture. 
The linkage between public health and 
agricultural use of insecticides plagues 
public health use of insecticides like 
DDT and pyrethroids, where agricultural 
applications are one of the major drivers 
of resistance in vector populations 
[13,17,90]. This linkage could be broken 
by choosing LLA insecticides which 
could not be profitably reformulated 
for agricultural use, and for which 
there is no cross-resistance with existing 
agricultural pesticides. Moreover, 
restricted to the much smaller public 
health arena, any environmental 
impact of LLA insecticides would also 
be substantially reduced. However, an 
insecticide exclusive to public health 
would be unable to exploit the financial 
drivers promoting investment in 
agricultural insecticides, and so would 
need an artificially constructed market 
of the sort necessary to encourage the 
pharmaceutical industry to invest in 
malaria vaccines.
Our argument that public health 
insecticides can be evolution-proofed 
will not generalize to all vector-borne 
diseases, but it may be applicable to 
others with extrinsic incubation periods 
that approach the life spans of their 
vectors. Such diseases may include 
dengue, filariasis, West Nile virus, 
Japanese encephalitis, onchocercaisis, 
and Chagas disease. Novel technologies 
directed against a variety of disease 
vectors, such as those exploiting 
genetic modification of mosquitoes 
and selfish genetic elements, could also 
be immune to the evolution of host 
resistance if they are late-life acting.
The Global Malaria Action Plan 
(GMAP) [10] has laudable ambitions of 
spraying 172 million houses annually, 
and distributing 730 million insecticide-
impregnated bed nets by the year 
2010. If implemented with existing 
insecticides, this program will impose 
unprecedented selection for resistance. 
The historical record [22], and theory 
(e.g., Figure 1) shows that the medium-
term prognosis for the insecticides 
currently in use is inescapably poor. 
Transitioning to an LLA insecticide 
strategy could see the benefits of the 
massive GMAP effort sustained, and 
could maintain for the long term the 
contribution of several key vector 
control tools to the goal of eradication. 
Failure to address evolution now runs 
the risk of replaying history [22]: 
operational disaster and a derailing of 
the whole malaria control agenda.
Materials and Methods
The aim is to compare the relative 
effects of various hypothetical 
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insecticides on (i) malaria 
transmission and (ii) evolution of 
resistance. Age-structured models of 
vector-borne diseases are notoriously 
difficult to parameterize, but because 
our aim is comparison of insecticides 
(our aim is theoretical proof-of-
principle), and not absolute rates or 
amounts, considerable simplification 
is possible. 
Our analysis consists of two parts: 
a static deterministic feeding cycle 
model (FCM) similar to those used 
by others [42–44], and a population 
genetics model (PGM). The FCM 
tracks, for each gonotrophic cycle over 
the lifetime of a mosquito (up to a 
maximum of ten cycles), probabilities 
of survival, contact with insecticides,
frequency and ages of malaria 
infections, and the number of eggs laid. 
Incorporation of relevant mortality 
assumptions allows the FCM to assess 
the impact of a particular insecticide 
on the average lifetime number of 
infectious bites per mosquito and the 
average fecundity per mosquito. The 
PGM then uses the survival, infectious 
bite, and fecundity figures from the 
FCM for each class of mosquito to 
calculate, for the population as a whole, 
the relative frequency of resistant 
mosquitoes (our measure of resistance 
evolution) and the average number 
of infectious bites per mosquito (our 
measure of control), over a series of 
time periods (each equivalent to the 
length of one gonotrophic cycle), 
using standard population genetics 
approaches.
The FCM makes the following 
assumptions.
Mosquitoes bite humans randomly 1.
and uniformly.
Malaria-infected mosquitoes never 2.
become uninfected.
The proportion of humans who are 3.
infectious is constant.
A variety of parameters do not 4.
change over successive gonotrophic 
cycles: (i) the background mosquito 
mortality rate (what Smith and 
McKenzie [44] call “force of 
mortality”), which is considered as a 
constant per-capita daily death rate 
(i.e. there is no senescence), (ii) the 
probability of taking a blood meal 
and (iii) the probability of feeding 
on a human.
Conventional insecticides are instant 5.
kill.
LLA insecticides are envisaged to 
kill in either of two ways: (i) when they 
contact a mosquito after she has been 
through a fixed number of gonotrophic 
cycles, e.g., a four-cycle age-dependent 
insecticide (ADI) kills mosquitoes 
that have been through four or more 
cycles; or (ii) a fixed number of cycles 
after first contact, as might be the case 
for an infectious agent, e.g., a four-
cycle time-delay insecticide (TDI) kills 
mosquitoes four cycles after initial 
contact. We have modeled both; the 
values we report are for ADIs. In Table 
S1, we show that ADIs and TDIs have 
equivalent effects. [Note that a mode of 
action for an LLA insecticide could also 
be via bioaccumulation, where lethal 
concentrations of an insecticide are 
finally achieved after repeated contacts 
over course of a mosquito’s life. We 
have not explicitly modeled that mode 
of action].
The non-mathematical description 
of the model, considering ADIs only, 
is as follows. Female mosquitoes are 
followed from successful emergence 
through ten gonotrophic cycles. In 
each cycle, the probabilities of survival 
are tracked through the processes of 
host seeking, feeding, resting, finding 
an oviposition site, and laying. For each 
cycle, the proportion of mosquitoes 
that acquire a malaria infection, bite 
whilst infectious for malaria, and 
successfully lay eggs is also recorded. 
The mosquito may die whilst searching 
for a host, with a probability arising 
from the time spent searching and 
the background mortality rate. If she 
survives searching, she then attempts 
to feed on a human with a given 
probability, and on a nonhuman with 
one minus that probability. She may die 
whilst attacking the host immediately 
before or immediately after feeding, 
with probabilities calculated from 
the underlying risk of death when 
attacking a host, and the probability 
of encountering an insecticide 
(conventional or ADI) that kills on 
contact. Of those that successfully feed 
on a human host, females carrying 
a mature malaria infection give an 
infectious bite, whilst those so far 
uninfected may become infected, with 
a fixed probability. Those that survive 
feeding may then die during resting 
with a probability calculated from the 
time spent resting, and the background 
mortality rate. Those surviving resting 
may die whilst searching for a resting 
site, again depending on time and 
relevant mortality rates, and survivors 
may then die whilst attempting to lay, 
either before or after laying, with fixed 
probabilities. The tracked values give 
the proportion of mosquitoes surviving, 
biting, and laying in each cycle. 
The variables and parameters used 
in the FCM to generate the figures 
reported in the paper are given in 
Table S2 with equations in Protocol 
S1. Differential mortality of malaria-
infected and uninfected mosquitoes 
was calculated by applying only a 
proportion of the mortality associated 
with a given treatment to individuals 
not infected with malaria. The full 
mortality is applied to malaria-
infected individuals. The model was 
implemented in Microsoft Excel [91].
The PGM makes the following 
assumptions:
Adult mosquito population size is 1.
constant.
Mosquitoes do not complete more 2.
than ten gonotrophic cycles. 
The genetic make-up of mating 3.
males in any cycle is the same as 
that calculated for newly hatched 
mosquitoes in that cycle.
Males of all resistant/susceptibility 4.
genotypes are equally likely to mate 
successfully.
Females mate once only, in their 5.
first cycle, as is the norm [45].
Number of eggs produced per 6.
laying female is unaffected by egg 
paternal genotype.
Genotypes of emerging adults 7.
joining the population are in the 
same proportions as the genotypes 
of the generation of eggs from 
which they hatch.
Resistance is dominant, as can be 8.
the case [52]. 
Costs of resistance are dominant.9.
The proportion of infectious 10.
humans is constant.
Variables and parameter values 
for the PGM are given in Table S3 
and associated equations are given 
in Protocol S2. The model uses 
survival probabilities from the FCM 
to calculate the initial age structure 
within the susceptible phenotypes in 
the population. The resistant allele 
is assumed initially to be present in 
heterozygotes, forming a very small 
proportion of the population, as 
detailed in Table S3. Subsequent 
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spread of the allele reflects the 
age-linked survival probabilities for 
susceptible mosquitoes in the presence 
of the treatment and for resistant 
individuals, as well as the age-linked 
fecundity of each, all calculated in 
the FCM. The model, implemented 
in Microsoft Excel [91], analyses the 
changing status of the population for 
1,290 sequential discrete time periods, 
each equivalent to the length of one 
feeding cycle.
Further discussion of model 
assumptions and sensitivity analyses 
are given in Text S1, together with 
additional analysis of the merits of the 
approach.
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Protocol S1.  Mathematical details of the Feeding Cycle Model 
Using the symbols in Table S2, the calculation of average mosquito survival probabilities, normalized egg 
production and average infectious bites per cycle is as follows. 
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Protocol S2.  Mathematical details of the Population Genetics Model 
Using the symbols detailed in Table S3, the calculation of the spread of resistant phenotypes in the population 
was as follows. 
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Efficacy of treatment is given as 
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Table S1.  Time-dependent insecticides and age-dependent insecticides have equivalent effects on disease 
transmission and resistance evolution.   Comparisons are made at 80% exposure, with mortality occurring 4 
cycles after contact (time-dependent inseciticide, TDI) or in mosquitoes aged 4 cycles or older (age-dependent 
insecticide, ADI).  
 
Cycle number
C1 C2 C3 C4 C5 C6 C7 C8 C9 C10
Time-dependent insecticide
Of the mosquitoes 
surviving to cycle 4, 
80% were exposed to 
TDI in cycle 1, and will 
now die as a result
Of the mosquitoes 
surviving to cycle 5, 
80% were exposed to 
TDI in cycle 2, and will 
now die as a result
 and so on......
Mortality in cycle from LLA 0.0% 0.0% 0.0% 80% 80% 80% 80% 80% 80% 80%
Age-dependent insecticide
Of the mosquitoes 
surviving to cycle 4, 
80% are now exposed 
to ALI, of which all are 
4 cycles of age or older, 
and will die as a result
Of the mosquitoes 
surviving to cycle 5, 
80% are now exposed 
to ALI, of which all are 
4 cycles of age or older, 
and will die as a result
 and so on......
Mortality in cycle from LLA 0.0% 0.0% 0.0% 80% 80% 80% 80% 80% 80% 80%
No mortality from 
treatment, no mosquitoes 
carrying TDI for 4 cycles
No mortality from 
treatment, no mosquitoes 4 
cycles or older
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Table S2.  Variables and parameters for the Feeding Cycle Model.   
 
 
Variable or Parameter 
 
 
Symbol
 
Value or 
Constraints 
 
 
Source 
(where 
relevant) 
Base instantaneous mortality rate per day r 0.12  a 
Length of gonotrophic cycle (days) w 2.85  a 
Time spent host searching and feeding during a cycle  (days) b 1.26 b 
Time spent finding oviposition site and laying during a cycle (days) φ 1.26 b 
Length of resting period (days) η 0.32 b 
Time required for parasite sporogonic development (days) d 10.78 a 
Proportion human population infectious for malaria p 0.04 a,c 
Probability attacks non-human host H 0.17 a 
Probability killed when attacking host before biting a1 0.05 d 
Probability killed when attacking host after biting (excluding 
mortality from insecticide treatments) a2 0.05 d 
Probability becomes infected with malaria when biting infectious 
human host M 0.80 
 
Cycle number (identifies specific cycle in the ten cycles over which 
average probabilities are tracked in the FCM) 
i 0≤ i ≤10  
Probability contacts and is killed by instant action (conventional or 
age-dependent) treatment when attacking human host, before biting 
ki 
for 
conventional 
chem  
ki = 0.80  
i=1,2..10 
for ALI 
 ki = 0  
i<effective 
age 
ki = 0.8  
i≥effective 
age 
 
 
Malaria status, the number of whole or partial cycles since infection 
with malaria m 
0≤m≤10 
m = 0 means 
not infected 
 
Differential mortality factor 
δ 
δ = 1 when 
m>0 
 
0 ≤ δ ≤ 1 
when  m=0  
 
Type of host attacked 
h 
h=1, non-
human 
h=2, non-
infectious 
human 
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Variable or Parameter 
 
 
Symbol
 
Value or 
Constraints 
 
 
Source 
(where 
relevant) 
h=3, 
infectious 
human 
Normalised number of eggs laid per successfully laying mosquito per 
cycle L 100 
 
Average normalised number of eggs laid in cycle i by mosquitoes 
surviving to the start of cycle i Fi  
 
Average normalised number of eggs laid in cycle i, by mosquitoes 
starting cycle i with malaria status m fi,m m<i  
 
Average probability of survival from start of cycle i to start of cycle 
i+1 Si  
 
Average probability that a mosquito starting cycle i with malaria 
status m, will survive to start of cycle i+1 si,m m<i 
 
Average probability of a mosquito being alive at start of period i. Vi   
Average probability of a mosquito being alive, with malaria status m 
at start of period i. vi,m, m<i 
 
Probability that a mosquito alive at start of cycle i with malaria status 
m, survives and bites host type h in cycle i qi,m,h m<i   
 
Probability that a mosquito alive at start of cycle i with malaria status 
m having survived to bite, then survives to lay eggs zi,m, m<i  
 
Average number of infectious bites in cycle i per mosquito alive at 
the start of cycle i Ii  
 
Average lifetime number of infectious bites per mosquito u   
Time, measured in whole units equal to length of sporogonic cycle, 
from infection of mosquito to cycle from which mosquito gives 
infectious bites 
D 0<D≤10 
 
 
a.1 Average value, based on data from four foci of intense malaria [1] 
b.  Assuming c.11.1% of every cycle is spent resting (8 hours in a 72 hour cycle), with the rest of the 
gonotrophic cycle divided equally between laying and feeding 
c.  Derived from overall probability biting human host will result in malaria infection in mosquito [1] 
d.  Based on 0.10 mortality during attack [2], assuming equal probabilities of death before and after a feed. 
 
References 
1. Killeen GF, McKenzie FE, Foy BD, Schieffelin C, Billingsley PF, et al. (2000) A simplified model for 
predicting malaria entomologic inoculation rates based on entomologic and parasitologic parameters 
relevant to control. American Journal of Tropical Medicine and Hygiene 62: 535-544. 
 
2. Killeen GF, Smith TA (2007) Exploring the contributions of bed nets, cattle, insecticides, and 
excitorepellency to malaria control: a deterministic model of mosquito host-seeking behaviour and 
mortality. Transactions of the Royal Society of Tropical Medicine and Hygiene 101: 867-880. 
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Table S3.  Variables and parameters for Population Genetics Model.  Time periods are equal in length to 
gonotrophic cycles, but we use cycles to refer to units of mosquito age and periods to refer to units of time. 
 
 
 
Variable or Parameter 
 
 
Symbol
 
Value or 
Constraints 
 
Period number (periods over which the population is tracked) n      0≤n≤1290 
Mosquito age (gonotrophic cycles) i 0 < i ≤ 10 
Phenotype j   susceptible j = 1   resistant j = 2 
Probability of survival for mosquitoes with phenotype j,  to age i+1 
from age i     (i>=1) Sj,i values from FCM 
Number of periods between egg laying and adult emergence l 3 
Dominance of resistance allele d   dominant d = 1   recessive d = 0 
Genotype (normal allele s, resistant allele r) g 
  (s,s)  g = 1 
  (s,r)  g = 2 
  (r,r)  g = 3 
Allele a as proportion alleles contributed by male population in 
period n Aa,n 
s      a = 1 
r      a = 2 
Proportion of mosquitoes with genotype g which survives from 
period n to period  n+1 Pg,n  
Proportion of mosquitoes with genotype g which are age i at start of 
period n Cg,n,i  
Normalised average number of eggs laid by females of phenotype j, 
aged i Fj,i values from FCM 
Total normalised number of eggs with genotype g laid in period n Bg,n  
Proportion of all eggs laid in period n having genotype g Eg,n  
Proportion of all new adults having genotype g at start of period n Ng,n N2,1=10-9 
Proportion of total population having genotype g at start of period n 
Gg,n 
G1,0 = 1-G2,0 
G2,0 = 10-9 
G3,0 = 0 
Proportion of the population surviving period n Ln  
Proportion of the population resistant at start of period n Rn  
Fitness factor for males with genotype g fg 1.00 
Average normalised number of infectious bites per mosquito of 
phenotype j aged i in period n Ij,n,i values from FCM 
Average normalised number of infectious bites per mosquito per 
cycle in a susceptible population, in absence of treatment  us value from FCM 
Average normalised number of infectious bites per mosquito in 
population in period n Mn  
Efficacy of treatment in period n Tn  
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Text S1.  Additional discussion of assumptions 
The model framework we have used here is designed to allow comparisons of the control and evolutionary 
outcomes of insecticides with different modes of action: relative performance is assessable, but the model is 
inadequate for predicting absolute time lines or impact on human morbidity and mortality.   One key model 
assumption is that the human malaria rate (proportion of people infectious with malaria) is constant.  We note 
that the effect of this assumption is to underestimate the relative public health benefits of LLA insecticides. 
Conventional insecticides have little room for improvement (in the scenarios modeled in Figs 1-3, they reduce 
infectious mosquitoes by 99.8% from the outset), whereas initial control benefits of LLA insecticides can 
improve as malaria rates fall in the human population. Such changes, and the problems of knowing what 
alternative strategies will be implemented once conventional insecticides fail, is also why we have not 
attempted to compare insecticides using some measure of cumulative transmission over the lifetime of a given 
product.  Another assumption is that total mosquito densities are unaffected by the insecticides.  Conventional 
insecticides do clearly reduce mosquito densities [e.g. 1] but, again, this can have little impact on the near 
perfect control they exert before resistance begins to evolve. LLA insecticides would be unlikely to significantly 
reduce overall mosquito numbers.   
 
Any model of vector-borne diseases is parameter and assumption rich.  We performed sensitivity analyses on 
the following to assess the significance of various assumptions. In all cases, key conclusions were unchanged by 
alterations in the given parameters within biologically sensible ranges, although in some cases a 3-cycle killer 
optimized the combination of malaria control and evolution-proofing. 
 
• Prevalence of malaria in the human population 
• Coverage (% exposure to insecticide treatments) 
• Combined effects of coverage and prevalence of malaria in the human population. 
• Separate analyses for each of the four different geographical sites [2] which we averaged to get the 
parameter values used in the model outputs reported in the paper   
• Genetic make-up of males in each cycle matching that of female population or of new adults only 
• Costs of resistance accrue solely as reduced fecundity  
• Recessivity of resistance and of costs of resistance.  Clearly evolution proceeds more slowly if resistance 
is recessive, but because comparison of different insecticides is the key output, our conclusions are 
qualitatively the same if we assume recessivity  
 
We also made a number of other assumptions that bear comment. 
 
We assumed that insecticides do not affect vector densities.  It seems likely that LLA insecticides acting on 
older age classes only may indeed have negligible impact on vector population sizes, since they will eliminate 
only the fecundity of older mosquitoes, and those mosquitoes, being relatively rare, will contribute negligibly to 
mosquito population growth rates.  In contrast, conventional insecticides are used to suppress Anopheles 
densities so that part of their effectiveness comes about by alterations in the vector:human ratio.  Our 
conclusions regarding the relative initial control efficacy of conventional and LLA insecticides are nonetheless 
robust to violation of our assumption of constant mosquito densities because in the scenario we modeled, 
conventional insecticides provided a level of initial control that was so high it could only be very slightly 
improved by reductions in vector densities. 
 
Our model assumes no mosquito senescence and no fitness effects of malaria infection.  Yet mosquitoes do 
senesce [3-6] and malaria has pronounced effects on mosquito fitness, perhaps by reducing vector survival [7] 
but particularly by reducing host fecundity [8,9].  We note that both senescence and malaria-induced fitness 
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reductions will further enhance the evolution-proofing of insecticides which disproportionately kill old and/or 
malaria-infected mosquitoes.  This is because any reductions in mosquito fitness through other factors reduce 
the relative fitness impact of insecticides, thus reducing selection for resistance.  Alternatively, it could be that 
longer lived mosquitoes live longer because they have higher viability, and consequently more late-life 
reproduction.  If this resulted in a higher proportion of their offspring produced later in life, this would 
strengthen selection for resistance in that fraction of the population transmitting malaria, perhaps slightly 
strengthening selection for resistance.  We are currently investigating the effects of different assumptions about 
age-specific mortality and reproduction and a thorough analysis of these will be published elsewhere. 
 
Complete evolution-proofing can be achieved if there are high enough costs of resistance. The actual magnitude 
of the costs of insecticide resistance in Anopheles are unclear; there has been remarkably little work done on the 
topic considering the critical role costs of resistance play in conventional resistance management.  The 
quantitative estimate we give in the main text is the only estimate of the relative fitness of resistant mosquitoes 
in the field of which we are aware.  This comes from the non-malarial vector, Culex pipiens, following 40 years 
of organophosphorous (OP) insecticide spraying in the Montepellier region of Southern France [10,11].  OP 
insecticides kill by inhibiting acetlycholinesterase in the central nervous system. As in Anopheles [12], 
resistance to OPs in Culex is encoded by a single amino acid mutation at position 119 of the ace-1 locus.  This  
mutation results in a 60% reduction in enzymantic activity, which probably underlies the variety of 
developmental and behavioural problems experienced by Culex mosquitoes with this mutation [10,11].  The 
frequency of the ace-1R mutation declines across a transect running from an OP-treated region into an untreated 
region.  The cost of resistance we discuss in the main text is the cost which Labbe et al. [10] estimate is required 
to account for the rate of decline in the frequency of the ace-1R mutation across that transect. Costs of resistance 
can be eroded by the spread of compensatory mutations.  There is little doubt that resistance evolution is 
continuing around the Montpellier region of Southern France, with new resistance alleles continuing to appear 
[10].  This means that the cost estimates we cite in the main text need not be the minimum evolution eventually 
achieves.  Nonetheless, we note that the estimate we are using is that seen after 40 years of spraying, suggesting 
that costs might have been even higher once, and that simple compensatory mutations of large effect rendering 
resistance effectively costless do not appear readily. 
 
Finally, a the slower evolution of resistance driven by LLA insecticides (Fig 1 in main paper) is not a 
consequence of weaker selection accruing from poorer initial control.  For instance, a conventional insecticide 
at a coverage of 50.1% achieves an initial control of 94.2%, which is the same as that for the 4-cycle age-
specific killer at 80% coverage reported in the paper.   But even at that lower coverage, the conventional 
insecticide has a useful lifespan about 1/5 that of LLA at the higher coverage. 
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